Genmab — Februar 2018
-
Hej alle, Hermed spørgsmål fra Hollandsk investor i Genmab. Jeg er bekendt med identiteten. Håber at han får nogle gode input. http://www.proinvestor.com/index.php?p=debat_1&postid=76050
-
Regarding the Dutch investor I recon its possible to trade short with one hand in a hedge fund firm and with the other hand trade some 5xbull in a subsidiary firm. Say go short 1.5% and then go long in 5 x bull for 1/3 of the short positions value. However then we should see some heavy activity in the trading of bull certificates. Not sure if that is the case.
-
The question I have to the Dutch investor is that if some of the big shore holders are not willing to sell below the 4 times higher intrinsic value ( around 4000 ) then why do the not buy some more Genmab shares if they are so sure that Genmab might be wort 4000kr and that a takeover could be close
-
-
Jeg er bange for at høje medicinpriser vil blive et tema hvor Trump og demokraterne kan blive enige http://www.washingtonexaminer.com/trump-promises-drug-prices-will-come-down/article/2647600
-
og det vil ikke være godt for Genmab eller andre i biotechsektoren
-
Anonyme igen øverst på køb og Nordnet på salg.
-
-
Succesraten for lægemiddeludvikling er større end ventet
Kliniske forsøg fører i højere grad end forventet til godkendelser af nye lægemidler, viser ny rapport. Forskning i medicin, der bruger kroppens immunsystem til bekæmpelsen af kræft, og personlig medicin er blandt grundene til resultaterne.
(medwatch.dk)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind